Yuyu Pharma, Inc. (KRX:000220)
4,260.00
+35.00 (0.83%)
At close: Dec 5, 2025
Yuyu Pharma Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 67,084 | 72,903 | 85,445 | 102,750 | 130,082 | 108,199 | Upgrade
|
| Market Cap Growth | -4.37% | -14.68% | -16.84% | -21.01% | 20.23% | 62.16% | Upgrade
|
| Enterprise Value | 80,936 | 76,861 | 119,950 | 114,352 | 120,293 | 117,748 | Upgrade
|
| Last Close Price | 4260.00 | 4505.00 | 5162.01 | 6081.01 | 7509.62 | 6924.50 | Upgrade
|
| PE Ratio | 14.79 | 9.62 | - | - | - | 108.35 | Upgrade
|
| PS Ratio | 0.48 | 0.55 | 0.62 | 0.74 | 1.13 | 1.10 | Upgrade
|
| PB Ratio | 0.48 | 0.54 | 0.71 | 0.83 | 1.01 | 0.92 | Upgrade
|
| P/TBV Ratio | 0.55 | 0.61 | 0.81 | 0.93 | 1.11 | 0.99 | Upgrade
|
| P/FCF Ratio | 26.08 | 4.09 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 7.47 | 2.92 | 203.03 | - | 28.85 | - | Upgrade
|
| EV/Sales Ratio | 0.58 | 0.58 | 0.87 | 0.82 | 1.04 | 1.20 | Upgrade
|
| EV/EBITDA Ratio | 4.81 | 4.21 | 24.69 | 25.78 | 21.09 | 11.58 | Upgrade
|
| EV/EBIT Ratio | 7.23 | 6.11 | - | - | 100.23 | 18.78 | Upgrade
|
| EV/FCF Ratio | 31.46 | 4.31 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.21 | 0.25 | 0.33 | 0.32 | 0.30 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 1.75 | 1.84 | 8.11 | 8.86 | 6.87 | 1.96 | Upgrade
|
| Debt / FCF Ratio | 11.25 | 1.89 | - | - | - | - | Upgrade
|
| Asset Turnover | 0.69 | 0.66 | 0.70 | 0.72 | 0.67 | 0.67 | Upgrade
|
| Inventory Turnover | 2.00 | 1.98 | 2.11 | 2.64 | 2.89 | 2.60 | Upgrade
|
| Quick Ratio | 0.92 | 0.97 | 1.14 | 0.86 | 2.43 | 2.20 | Upgrade
|
| Current Ratio | 1.77 | 1.58 | 2.03 | 1.50 | 3.30 | 3.50 | Upgrade
|
| Return on Equity (ROE) | 5.40% | 8.06% | -4.55% | -3.51% | -0.75% | 2.32% | Upgrade
|
| Return on Assets (ROA) | 3.37% | 3.88% | -0.24% | -0.19% | 0.43% | 2.68% | Upgrade
|
| Return on Capital (ROIC) | 4.06% | 4.79% | -0.29% | -0.22% | 0.49% | 3.08% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.40% | 8.80% | -0.50% | -0.50% | 0.70% | 4.60% | Upgrade
|
| Earnings Yield | 7.29% | 11.96% | -8.40% | -5.83% | -1.70% | 1.19% | Upgrade
|
| FCF Yield | 3.84% | 24.47% | -4.79% | -11.20% | -1.20% | -13.60% | Upgrade
|
| Dividend Yield | 2.37% | 2.22% | - | - | - | - | Upgrade
|
| Payout Ratio | 31.97% | - | - | - | - | 118.38% | Upgrade
|
| Buyback Yield / Dilution | -9.19% | -3.29% | 1.89% | -3.90% | -32.81% | 19.87% | Upgrade
|
| Total Shareholder Return | -6.83% | -1.07% | 1.89% | -3.90% | -32.81% | 19.87% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.